Imbruvica

AbbVie and J&J claim new Imbruvica okay in US

https://pharmaphorum.com/news/abbvie-and-jj-claim-new-imbruvica-okay-in-us/

AbbVie and J&J’s Imbruvica fails pancreatic cancer test

https://pharmaphorum.com/news/abbvie-and-jjs-imbruvica-fails-pancreatic-cancer-test/

China’s BeiGene delays US filing for rival to Imbruvica

https://pharmaphorum.com/news/chinas-beigene-delays-us-filing-for-rival-to-imbruvica/

Janssen’s Imbruvica latest to gain NICE approval after price cut

https://pharmaphorum.com/news/janssens-imbruvica-latest-gain-nice-approval-price-cut/

Decision to axe Afinitor ‘confirms worst fears’ for Cancer Drug Fund

https://pharmaphorum.com/news/decision-axe-afinitor-confirms-worst-fears-cancer-drug-decisions/

Imbruvica, Opdivo and Praluent gain approvals for Scotland’s NHS

https://pharmaphorum.com/news/imbruvica-opdivo-praluent-gain-approvals-scotlands-nhs/

Close in 10 seconds

Pharmaphorum.com

Search